Brief: TCR² Therapeutics Reports Expansion of U.S. Manufacturing Capacity
01/11/2021 22:06
Nov 1 (Reuters) - TCR2 Therapeutics Inc TCRR.O :
* TCR² THERAPEUTICS ANNOUNCES EXPANSION OF U.S.
MANUFACTURING
CAPACITY
* TCR2 THERAPEUTICS INC - EXPANSION OF ITS MANUFACTURING
CAPACITY
BY EXERCISING AN OPTION ON A SECOND CLEAN ROOM AT ELEVATEBIO
BASECAMP
* TCR2 THERAPEUTICS INC - SECOND CLEAN ROOM AT ELEVATEBIO
BASECAMP
WILL EXPAND CGMP CAPACITY FOR CLINICAL TRIALS IN 2022
* TCR2 THERAPEUTICS INC - PROPOSES TO CEASE MANUFACTURING
ACTIVITIES AT CELL AND GENE THERAPY CATAPULT (CGT CATAPULT) IN
STEVENAGE, UK
Source text for Eikon: ID:nGNX8Qf24H
Further company coverage: TCRR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TCR2 Therapeutics
See all newsBrief: TCR2 Therapeutics Entered Into An Assignment Of Lease Agreement With Astrazeneca
TCR2 Therapeutics falls on bigger-than-expected Q1 loss
Brief: Tcr² Therapeutics Reports Q1 2023 Financial Results And Provides Corporate Update
TCR2 Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
TCR2 Therapeutics Inc expected to post a loss of 68 cents a share - Earnings Preview